SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019294
Filing Date
2022-05-10
Accepted
2022-05-10 16:23:51
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-10q_20220331.htm   iXBRL 10-Q 2333570
2 EX-31.1 abcl-ex311_126.htm EX-31.1 20973
3 EX-31.2 abcl-ex312_125.htm EX-31.2 20939
4 EX-32.1 abcl-ex321_124.htm EX-32.1 9463
5 EX-32.2 abcl-ex322_123.htm EX-32.2 9440
6 GRAPHIC gdi4lhrvklds000001.jpg GRAPHIC 102445
  Complete submission text file 0001564590-22-019294.txt   6926651

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA abcl-20220331.xsd EX-101.SCH 42568
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abcl-20220331_cal.xml EX-101.CAL 51331
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abcl-20220331_def.xml EX-101.DEF 147376
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20220331_lab.xml EX-101.LAB 344332
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20220331_pre.xml EX-101.PRE 264611
59 EXTRACTED XBRL INSTANCE DOCUMENT abcl-10q_20220331_htm.xml XML 946271
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 22910071
SIC: 2834 Pharmaceutical Preparations